About the bill
Although health care is one of the most partisan political subjects, a new health care law was just signed with almost unanimous support. The FDA Reauthorization Act of 2017 aims to lower prescription drug prices, amid skyrocketing health insurance costs.
What the law does
The law is an amalgamation of provisions from at least eight different standalone healthcare-related bills which had been introduced earlier this year from both parties. Among its most notable provisions:
- Reauthorizes so-called “user fees” to the Food and Drug Administration for five years. These fees are ...
Sponsor and status
Sponsor. Representative for Oregon's 2nd congressional district. Republican.
Last Updated: Aug 5, 2017
Length: 86 pages
May 16, 2017
115th Congress, 2017–2019
Enacted — Signed by the President on Aug 18, 2017
This bill was enacted after being signed by the President on August 18, 2017.
This bill incorporates provisions from:
S. 934: FDA Reauthorization Act of 2017
Ordered Reported on May 11, 2017. 63% incorporated. (compare text)
S. 1062: FDA Reporting Transparency and Accountability Act
Introduced on May 4, 2017. 29% incorporated. (compare text)
S. 1069: Medical Device Safety Monitoring Act
Introduced on May 8, 2017. 66% incorporated. (compare text)
S. 1509: Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017
Introduced on Jun 29, 2017. 46% incorporated. (compare text)
S. 1048: Enhanced Clinical Trial Design Act of 2017
Introduced on May 4, 2017. 76% incorporated. (compare text)
H.R. 1652: Over-the-Counter Hearing Aid Act of 2017
Introduced on Mar 21, 2017. 93% incorporated. (compare text)
H.R. 2430 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2018). H.R. 2430 — 115th Congress: FDA Reauthorization Act of 2017. Retrieved from https://www.govtrack.us/congress/bills/115/hr2430
“H.R. 2430 — 115th Congress: FDA Reauthorization Act of 2017.” www.GovTrack.us. 2017. January 20, 2018 <https://www.govtrack.us/congress/bills/115/hr2430>
|title=H.R. 2430 (115th)
|accessdate=January 20, 2018
|author=115th Congress (2017)
|date=May 16, 2017
|quote=FDA Reauthorization Act of 2017
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.